Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $563,652 (100.0% shares, 0.0% debt)

Holdings (9)

— ABIOMED INC 28.3%

Value ($000) $159,634 Shares 946,818 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 22.4%

Value ($000) $126,511 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— CORIUM 18.4%

Value ($000) $103,635 Shares 9,353,304 Est. Cost $7.77 Unrealized —

AXGN AXOGEN INC 16.7%

Value ($000) $94,062 Shares 4,861,111 Est. Cost $4.01 Unrealized +319.4%

— ENTELLUS MEDICAL INC 10.6%

Value ($000) $59,656 Shares 3,231,656 Est. Cost $21.90 Unrealized —

— ENDOLOGIX INC 2.0%

Value ($000) $11,415 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.3%

Value ($000) $7,455 Shares 1,170,370 Est. Cost $2.95 Unrealized +80.3%

ACUR ACURA PHARMACEUTICALS INC 0.2%

Value ($000) $880 Shares 1,956,397 Est. Cost $3.40 Unrealized -86.1%

— CATALYST 0.1%

Value ($000) $404 Shares 78,622 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	946,818	$159,634	28.3%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$126,511	22.4%	$31.50	—	COM	761330109
—	CORIUM	9,353,304	$103,635	18.4%	$7.77	—	COM	21887L107
AXGN	AXOGEN INC	4,861,111	$94,062	16.7%	$4.01	+319.4%	COM	05463X106
—	ENTELLUS MEDICAL INC	3,231,656	$59,656	10.6%	$21.90	—	COM	29363K105
—	ENDOLOGIX INC	1,257,468	$11,415	2.0%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$7,455	1.3%	$2.95	+80.3%	COM	58468P206
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$880	0.2%	$3.40	-86.1%	COM	00509L802
—	CATALYST	78,622	$404	0.1%	$4.80	—	COM	14888D109